IDYA IDEAYA Biosciences Inc

Price (delayed)

$41.39

Market cap

$3.13B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.01

Enterprise value

$3.03B

IDEAYA Biosciences Inc. is a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates ...

Highlights
IDEAYA Biosciences's equity has surged by 180% YoY and by 51% QoQ
The quick ratio has soared by 146% YoY and by 44% from the previous quarter
The net income has plunged by 89% YoY and by 14% from the previous quarter
The company's gross profit has shrunk by 67% YoY and by 34% QoQ

Key stats

What are the main financial stats of IDYA
Market
Shares outstanding
75.69M
Market cap
$3.13B
Enterprise value
$3.03B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.3
Price to sales (P/S)
200.51
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
195.17
Earnings
Revenue
$15.5M
EBIT
-$128.89M
EBITDA
-$124.76M
Free cash flow
-$134.85M
Per share
EPS
-$2.01
Free cash flow per share
-$1.8
Book value per share
$12.54
Revenue per share
$0.21
TBVPS
$12.8
Balance sheet
Total assets
$961.53M
Total liabilities
$26.22M
Debt
$2.41M
Equity
$935.31M
Working capital
$684.39M
Liquidity
Debt to equity
0
Current ratio
28.42
Quick ratio
28.03
Net debt/EBITDA
0.86
Margins
EBITDA margin
-804.7%
Gross margin
100%
Net margin
-831.4%
Operating margin
-1,026.6%
Efficiency
Return on assets
-19.3%
Return on equity
-20.1%
Return on invested capital
-25.1%
Return on capital employed
-13.8%
Return on sales
-831.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IDYA stock price

How has the IDEAYA Biosciences stock price performed over time
Intraday
3.48%
1 week
4.76%
1 month
8.61%
1 year
82.58%
YTD
16.33%
QTD
17.89%

Financial performance

How have IDEAYA Biosciences's revenue and profit performed over time
Revenue
$15.5M
Gross profit
$15.5M
Operating income
-$159.17M
Net income
-$128.89M
Gross margin
100%
Net margin
-831.4%
IDYA's operating income has dropped by 113% year-on-year and by 18% since the previous quarter
The net income has plunged by 89% YoY and by 14% from the previous quarter
IDEAYA Biosciences's operating margin has plunged by 79% from the previous quarter
The company's net margin has shrunk by 72% QoQ

Growth

What is IDEAYA Biosciences's growth rate over time

Valuation

What is IDEAYA Biosciences stock price valuation
P/E
N/A
P/B
3.3
P/S
200.51
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
195.17
The EPS has declined by 29% year-on-year and by 2.6% since the previous quarter
IDEAYA Biosciences's equity has surged by 180% YoY and by 51% QoQ
The stock's P/B is 39% above its 5-year quarterly average of 2.3
The stock's price to sales (P/S) is 95% more than its last 4 quarters average of 99.6
The revenue has dropped by 67% year-on-year and by 34% since the previous quarter

Efficiency

How efficient is IDEAYA Biosciences business performance
The return on sales has dropped by 72% since the previous quarter
IDYA's ROIC is up by 17% from the previous quarter
The company's return on equity rose by 13% QoQ and by 2.9% YoY
The ROA has grown by 11% from the previous quarter but it has contracted by 6% YoY

Dividends

What is IDYA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IDYA.

Financial health

How did IDEAYA Biosciences financials performed over time
IDEAYA Biosciences's total assets has surged by 164% YoY and by 48% QoQ
The quick ratio has soared by 146% YoY and by 44% from the previous quarter
The company's debt is 100% lower than its equity
IDEAYA Biosciences's equity has surged by 180% YoY and by 51% QoQ
IDEAYA Biosciences's debt to equity has shrunk by 100% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.